Cardiac pacemakers

The report presents a summary of reimbursement situation for cardiac pacemakers.

Both single- and dual-chamber pacemakers are considered. Use of pacemakers is considered in complete atrioventricular block and obstructive hypertrophic cardiomyopathy.

Reimbursement analysis covers the following procedures: implantation, replacement and removal of pacemaker.

The only reimbursement within public / statutory health insurance systems is considered.

Report includes essential information about reimbursement and national funding, including:

• Brief overview of reimbursement system for medical devices
• Procedure coding for technology
• Diagnosis coding
• Payment mechanism for technology
• Reimbursement tariffs for technology
• Restrictions in indications or scenarios for use of technology
• Policy considerations by payers and policy-makers about technology

Reimbursement information is provided for the following geographies:

• Austria
• Belgium
• Denmark
• England (UK)
• France
• Germany
• Italy
• Netherlands
• Norway
• Sweden
• Switzerland

Manufacturers of devices for cardiac pacemakers include:

• Abbott Vascular (Assurity MRI, Endurity MRI)
• Biotronik (Enitra, Effecta, Epyra, Estella, Evia, Edora)
• Boston Scientific (Essentio, Accolade, Ingenio, Advantio, Vitalio)
• Qinming Medical (Qinming)
• MicroPort CRM (Kora, Reply, Esprit)
• Medico S.p.A. (Gea, Hera, Eos, Sophos, Helios, Mythos, Easy Plus)
• Medtronic (Azure, Advisa MRI, Adapta, Micra, Revo MRI SureScan, Sensia, Versa, EnRhythm, EnPulse, Sigma, Kappa)
• Pacetronix (Tiranga, Pinnacle, CHARAK, Pinnacle-R)
• Vitatron (Vitatron)